Detecting amyloid biomarkers: Embodied risk and Alzheimer prevention

BioSocieties

Volumn 8, Issue 2, 2013, Pages 107-123

  Lock, Margaret ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer biomarkers; molecular prevention; presymptomatic AD; randomized AD prevention trial; the amyloid cascade

Indexed keywords

EID: 84878552567     PISSN: 17458552     EISSN: 17458560     Source Type: Journal    
DOI: 10.1057/biosoc.2013.5     Document Type: Article

References (30)

1. BBC News. (2011) The Colombian Alzheimer's family testing possible cures. BBC News, 18 May.
2. Belluck, P. (2010a) Alzheimer's stalks a Colombian family. New York Times, 1 June.
3. Belluck, P. (2010b) A perplexing case puts a doctor on the trial of 'Madness'. New York Times, 2 June.
4. Bertram, L. and Tanzi, R. (2004) Alzheimer's disease: One disorder, too many genes? Human Molecular Genetics 13(Supplement 1): 135R-141R.
5. Brayne, C. (2007) The elephant in the room - Health brains in later life, epidemiology and public health. Nature Reviews Neuroscience 8(3): 233-239.
6. Breteler, M. (2011) Mapping out biomarkers for Alzheimer disease. Journal of the American Medical Association 305(3): 304-305.
7. Clark, C.M. et al (2011) Use of florbetapir-PET for imaging b-amyloid pathology. Journal of the American Medical Association 305(3): 275-283.
8. Finch, C.E. and Sapolsky, R.M. (1999) The evolution of Alzheimer disease, the reproductive schedule, and ApoE isoforms. Neurobiology of Aging 20(4): 407-428.
9. Fleisher, A.S. et al (2012) Florbetapir PET analysis of amyloid-b deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional study. The Lancet Neurology 11(12): 1057-1065.
10. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297(5580): 353-356. (Pubitemid 34790756)
11. Hardy, J.A. and Higgins, G.A. (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256(5054): 184-185.
12. Hendrie, H. (2009) Diagnosis of dementia and Alzheimer's disease in Indianapolis and Ibadan: Challenges in cross-cultural studies of aging and dementia. Alzheimer's & Dementia 5(4): 122.
13. Herskovits, A.Z. and Growdon, J.H. (2010) Sharpen that needle. Archives of Neurology 67(8): 918-920.
14. Holmes, C. et al (2008) Long-term effects of Ab42 immunization in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial. The Lancet 372(9634): 216-223. (Pubitemid 351978111)
15. Jack Jr, C.R. et al (2011) Introduction to the recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 7(3): 257-262.
16. Lippa, C.F. and Morris, J.C. (2006) Alzheimer neuropathology in nondemented aging: Keeping mind over matter. Neurology 66(12): 1801-1802. (Pubitemid 44049805)
17. Lishman, W.A. (1994) The history of research into dementia and its relationship to current concepts. In: C. Brayne Huppert and D.W. O'Conner (eds.) Dementia and Normal Aging, Vol. 41-56. Cambridge, UK: Cambridge University Press, pp. 50-52.
18. Lock, M. (2013) The Alzheimer's Conundrum: Entanglements of Aging and Dementia. Princeton, NJ: Princeton University Press.
19. Maurer, K. and Maurer, U. (1986) Alzheimer: The Life of a Physician and the Career of a Disease. New York: Columbia University Press.
20. Maury, C.P.J. (2009) The emerging concept of functional amyloid. Journal of Internal Medicine 265(3): 329-334.
21. Mudher, A. and Lovestone, S. (2002) Alzheimer's disease: Do Tauists and Baptists finally shake hands? Trends in Neurosciences 25(1): 22-26. (Pubitemid 34093781)
22. Perry, G., Nunomura, A., Raina, A.K. and Smith, M.A. (2002) Amyloid-b Junkies. The Lancet 355(9205): 757.
23. Reiman, E. et al (2012) Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the Presenilin 1 E280A kindred: A case-control study. The Lancet Neurology 11(12): 1048-1056.
24. Runciman, D. (2012) Will we be all right in the end? London Review of Books 34(1): 3-5.
25. Savva, G.M., Wharton, S.B., Ince, P.G., Forster, G., Matthews, F.E. and Brayne, C. (2009) Age, neuropathology, and dementia. New England Journal of Medicine 360(22): 2302-2309.
26. Snowdon, D. (2001) Aging with Grace: What the Nun Study Teaches Us about Leading Longer, Healthier and More Meaningful Lives. New York: Bantam Books.
27. Sperling, R.A. et al (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 7(3): 280-292.
28. Sullivan, M.G. (2011) Studies take aim at groups at high risk for Alzheimer's. WorldCare Clinical, 21 March. http://www.wcclinical.com/hivefire/ leading-cns-experience/studies-take-aim-at-groups-at-high-risk-foralzheimers/.
29. Wang, S-C., Oelze, B. and Schumacher, A. (2008) Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 3(7): e2698.
30. Weiss, K.M. and Buchanan, A.V. (2011) Is life law-like? Genetics 188(4): 761-771.